Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer-Reference-Cited by-同舟云学术

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer

Published:2019 Issue:5 Volume:11 Page:409-416
ISSN:1689-832X
Container-title:Journal of Contemporary Brachytherapy
language:
Short-container-title:jcb

Author:

Nakai Yasushi,Tanaka Nobumichi,Asakawa Isao,Torimoto Kazumasa,Miyake Makito,Anai Satoshi,Fujii Tomomi,Hasegawa Masatoshi,Fujimoto Kiyohide

Publisher

Termedia Sp. z.o.o.

Subject

Radiology Nuclear Medicine and imaging,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mirabegron Reduces Urinary Frequency and Improves Overactive Bladder Symptoms at 3 Months After 125I-brachytherapy for Prostate Cancer: An Open-Labeled, Randomized, Non–Placebo-Controlled Study;Urology;2021-12

2. Factors affecting urinary frequency after low‐dose‐rate brachytherapy for prostate cancer;LUTS: Lower Urinary Tract Symptoms;2021-07-20

3. A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study;Contemporary Clinical Trials Communications;2020-09

4. Biochemical control of the combination of cyclooxygenase‐2 inhibitor and 125 I‐brachytherapy for prostate cancer: Post hoc analysis of an open‐label controlled randomized trial;International Journal of Urology;2020-06-26

5. Toxicity in patients treated with permanent prostate brachytherapy using intraoperatively built custom-linked seeds versus loose seeds;Journal of Contemporary Brachytherapy;2020